New evidence on hyperkalaemia management in patients with heart failure, resistant hypertension and chronic kidney disease – The cardiologist’s perspective.

25 May 2019 (12:35 - 12:50)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Professor Ileana Pina

Thomas Jefferson University, Philadelphia (United States of America)

4 More presentations in this session

Presentation thumbnail

Welcome and introduction - Management of hyperkalaemia in patients with heart failure – Overcoming barriers to optimal renin-angiotensin-aldosterone system inhibitor therapy.

Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)

Presentation thumbnail

Hyperkalaemia in patients with heart failure – Addressing the unmet medical need.

Professor M. Lainscak (Murska Sobota, SI)

Presentation thumbnail

New evidence on hyperkalaemia management in patients with heart failure, resistant hypertension and chronic kidney disease – The nephrologist’s perspective.

Professor P. Rossignol (Monaco, MC)

Presentation thumbnail

Panel discussion and close - Management of hyperkalaemia in patients with heart failure – Overcoming barriers to optimal renin-angiotensin-aldosterone system inhibitor therapy.

Professor J. Butler (Dallas, US)

Access the full session

Session thumbnail

Management of hyperkalaemia in patients with heart failure – Overcoming barriers to optimal renin-angiotensin-aldosterone system inhibitor therapy

The Event

Heart Failure 2019

25 May 2019 12:35 CET

You may be interested in

Congress Presentation

Comorbidity burden assessed by the Charlson comorbidity index and its influence on prognosis of patients admitted due to heart failure

Congress Session

Chronic kidney disease and heart failure

Congress Presentation

Spectrum of non-cardiac comorbidities

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources